Double-Blind, Randomized, Placebo-Controlled, Phase IIb Clinical Trial to Investigate the Efficacy of RUTI® Therapeutic Vaccination as adjuvant of Tuberculosis chemotherapy
Latest Information Update: 24 May 2024
Price :
$35 *
At a glance
- Drugs Tuberculosis-vaccine-Archivel-Farma (Primary)
- Indications Tuberculosis
- Focus Therapeutic Use
- Sponsors Archivel Farma
- 21 May 2024 Planned End Date changed from 1 Nov 2025 to 1 Mar 2025.
- 21 May 2024 Planned primary completion date changed from 1 Nov 2025 to 1 Mar 2025.
- 21 May 2024 Status changed from recruiting to active, no longer recruiting.